Innovage Holding (INNV) Gross Profit Margin starting from the fourth quarter 2026 to fourth quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Innovage Holding Corp   (NASDAQ: INNV)


Innovage Holding 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INNV Gross Profit Margin (Jun 30 2026)
Q4 		(Mar 31 2026)
Q3 		(Dec 31 2025)
Q2 		(Sep 30 2025)
Q1 		(Jun 30 2025)
Q4
Y / Y Revenue Change 18.31 %
Seq. Revenue Change 3.97 %
Revenue In Millions $261.95
Gross Profit Margin 23.88 %
Gross Profit Margin Total Ranking # 1038
Gross Profit In Millions $62.56
Y / Y Gross Profit Change -58.14 %
Seq. Gross Profit Change -64.1 %


Commenting fourth quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 23.88 % due to increase in Cost of Sales and despite Revenue increase of 3.97 % to $262 millions.
Company's Gross Profit Margin in IV. Quarter, was lower than company average.


Observing fourth quarter 2026 results within Medical Equipment & Supplies industry 59 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1038, from total ranking in the previous quarter at 1106.
Learn about Gross Margin
INNV's Gross Profit Margin fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 188
Overall # 1030

Gross Profit Margin Statistics
High Average Low
89.87 % 68.94 % 14.17 %
(Dec 31 2014)   (Dec 31 2017)


INNV Gross Income Trends • More of INNV's Profitabilty Ratios • INNV Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
INNV's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
INNV's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for INNV's Competitors
Gross Profit Margin Profit Margin for Innovage Holding 's Suppliers
Gross Profit Margin Profit Margin for INNV's Customers

You may also want to know
INNV's Annual Growth Rates INNV's Profitability Ratios INNV's Asset Turnover Ratio INNV's Dividend Growth
INNV's Roe INNV's Valuation Ratios INNV's Financial Strength Ratios INNV's Gross Profit Growth
INNV's Roa INNV's Inventory Turnover Ratio INNV's Growth Rates INNV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Anika Therapeutics Inc   65.15 %$ 21.244  Millions$ 32.610  Millions
Koru Medical Systems Inc   65.14 %$ 7.846  Millions$ 12.045  Millions
Medtronic Plc  64.99 %$ 6,340.000  Millions$ 9,756.000  Millions
Biolife Solutions Inc   64.24 %$ 18.287  Millions$ 28.466  Millions
Safe Pro Group Inc   64.02 %$ 0.853  Millions$ 1.332  Millions
Apyx Medical Corp  63.89 %$ 8.870  Millions$ 13.884  Millions
Heartsciences Inc   63.81 %$ 0.001  Millions$ 0.002  Millions
Tenon Medical Inc   63.64 %$ 0.814  Millions$ 1.279  Millions
Dexcom Inc   63.44 %$ 830.000  Millions$ 1,308.400  Millions
Interpace Biosciences Inc   61.91 %$ 5.653  Millions$ 9.131  Millions
Clearpoint Neuro Inc   61.67 %$ 6.710  Millions$ 10.880  Millions
Dariohealth Corp   61.66 %$ 3.192  Millions$ 5.177  Millions
Enovis Corp  61.64 %$ 359.249  Millions$ 582.782  Millions
Sintx Technologies Inc   61.50 %$ 0.278  Millions$ 0.452  Millions
Haemonetics Corporation  59.76 %$ 202.803  Millions$ 339.380  Millions
Transmedics Group Inc   59.59 %$ 113.198  Millions$ 189.948  Millions
Lensar Inc   59.27 %$ 9.776  Millions$ 16.495  Millions
Beta Bionics Inc   59.04 %$ 18.902  Millions$ 32.013  Millions
Resmed Inc   58.84 %$ 861.219  Millions$ 1,463.647  Millions
Stereotaxis Inc   58.49 %$ 4.486  Millions$ 7.670  Millions
National Vision Holdings Inc   58.23 %$ 290.433  Millions$ 498.805  Millions
Solventum Corporation  58.22 %$ 1,286.000  Millions$ 2,209.000  Millions
Teleflex Incorporated  58.16 %$ 331.707  Millions$ 570.332  Millions
Infusystem Holdings Inc  57.98 %$ 21.413  Millions$ 36.933  Millions
Warby Parker Inc   57.94 %$ 136.457  Millions$ 235.511  Millions
Conmed Corporation  57.49 %$ 197.458  Millions$ 343.488  Millions
Vivos Therapeutics Inc   57.31 %$ 2.953  Millions$ 5.153  Millions
Femasys Inc   57.08 %$ 0.189  Millions$ 0.332  Millions
Tandem Diabetes Care Inc   56.87 %$ 144.780  Millions$ 254.560  Millions
Kestra Medical Technologies Ltd   56.50 %$ 17.498  Millions$ 30.971  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.